Table of Contents

company-logo

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Xvivo Perfusion Dividend Announcement

• Xvivo Perfusion does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Xvivo Perfusion dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Xvivo Perfusion Dividend History

Xvivo Perfusion Dividend Yield

Xvivo Perfusion current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Xvivo Perfusion stock? Use our calculator to estimate your expected dividend yield:

Xvivo Perfusion Financial Ratios

P/E ratio69.43
PEG ratio0.02
P/B ratio6.81
ROE10.14%
Payout ratio0.00%
Current ratio5.49
Quick ratio4.23
Cash Ratio2.98

Xvivo Perfusion Dividend FAQ

Does Xvivo Perfusion stock pay dividends?
Xvivo Perfusion does not currently pay dividends to its shareholders.
Has Xvivo Perfusion ever paid a dividend?
No, Xvivo Perfusion has no a history of paying dividends to its shareholders. Xvivo Perfusion is not known for its dividend payments.
Why doesn't Xvivo Perfusion pay dividends?
There are several potential reasons why Xvivo Perfusion would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Xvivo Perfusion ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Xvivo Perfusion has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Xvivo Perfusion a dividend aristocrat?
Xvivo Perfusion is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Xvivo Perfusion a dividend king?
Xvivo Perfusion is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Xvivo Perfusion a dividend stock?
No, Xvivo Perfusion is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Xvivo Perfusion stocks?
To buy Xvivo Perfusion you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Xvivo Perfusion stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.